Sponsors

Section: 

The National Health Council (NHC) envisions a society in which all people have access to quality health care that respects personal goals and aspirations, and is designed around the patient experience to promote their best possible health outcomes.

To accomplish this, our membership includes the nation’s most trusted patient advocacy organizations, as well as professional and membership associations, nonprofit organizations with an interest in health, and major branded and generic pharmaceutical, health insurance, medical device, and biotechnology companies.

By working with all stakeholders, we get things done to improve the health of people with chronic conditions – helping them to live longer and feel better.  To achieve our mission – providing a united voice for people with chronic diseases and disabilities and their family caregivers – we rely on a broad base of support.

Pursuant to our Standards of Excellence, the NHC discloses the financial support it receives from all sponsors. The NHC posts its disclosures on this webpage within six months of the close of the fiscal year.

Click here to view the full National Health Council Policy on Corporate Relationships.

Click here to view NHC's 2017 audited financials and 2018 budget

The companies and organizations below have provided funding for a variety of programmatic efforts including: qualitative and quantitative research; multi-stakeholder roundtables on topics ranging from patient engagement to utilizing real-world evidence; educational programs for patients and patient advocates; and several annual conferences. We gratefully acknowledge their support.

The following disclosure information includes the total amount of support received from each sponsor.

2017 Sponsors*

*Includes membership fees

In 2017, 72.1% of the NHC overall revenue came from insurance, pharmaceutical, biotechnology, and medical device companies. The specific amounts are: 

 

Corporate Sponsor

2017 sponsorship

2017 Dues Amount

Total Giving

Abbott

$30,000

19,100

$49,100

Advanced Medical Technology Association

10,000

9,100

19,100

Aetna

30,000

19,100

49,100

Alkermes, Inc.

90,000

19,100

109,100

Amgen

185,000

19,100

204,100

Anthem

 

19,100

19,100

Association for Accessible Medicines

27,500

9,100

36,600

Astellas Pharma US

30,000

19,100

49,100

AstraZeneca Pharmaceuticals

 

19,100

19,100

Biogen Inc.

20,000

19,100

39,100

Biotechnology Industry Organization

17,000

9,100

26,100

Boehringer Ingelheim Pharmaceuticals

35,000

19,100

54,100

Bristol-Myers Squibb

100,000

19,100

119,100

Celgene Corporation

 

19,100

19,100

 EMD Serono 4,775 19,100 23,875

Eli Lilly and Company

120,000

19,100

139,100

Genentech

 

19,100

19,100

GlaxoSmithKline

25,000

19,100

44,100

Grifols

20,000

19,100

39,100

Johnson & Johnson

100,000

19,100

119,100

Merck & Co.

220,000

19,100

239,100

NPC

59,500

19,100

68,600

Novartis

200,000

19,100

219,100

Novo Nordisk

 

19,100

19,100

Pfizer Inc

620,000

19,100

639,100

Pharmaceutical Research and Manufacturers of America

210,900

9,100

220,000

Purdue Pharma, LP

 

19,100

19,100

Sanofi

100,000

19,100

119,100

Shire Pharmaceuticals

 

19,100

19,100

Takeda Pharmaceuticals North America

 

19,100

19,100

UCB   19,100 19,100
       

Other 2017 Support

 

 

 

Nonprofit Member Contributions

30,500

 

 

PCORI Engagement Award

122,877

 

 

University of Maryland - Baltimore Contract 50,834    
Amgen Webinar Series 60,000